Table 2 Clinical, pathological and genomic features vs recurrent disease (N = 37)
N% Recurrent disease (N = 13) (35%) | N% Non-recurrent disease (N = 24) (64.9%) | P value | |
|---|---|---|---|
Age(mean) | 64.0 years | 61.8 years | p = 0.612 (t-test) |
Tumor grade | |||
G1 + G2 | 8.(62) | 14 (58) | |
G3 | 5 (38) | 10 (42) | p = 0.849 (chi-2) |
FIGO stage | |||
IA-IC | 8 (61) | 23 (96) | |
II | 5 (42) | 1 (4) | p = 0.007 (chi-2) |
Staging | |||
adequate | 1 (8) | 6 (25) | |
not adequate | 12 (92) | 18 (75) | p = 0.199 (chi-2) |
LOH detected | |||
at19q (51-56Mbp) | 8 (62) | 3 (12) | |
No. LOH at 19q | 5 (38) | 21 (88) | p = 0.002 (chi 2) |
(51-56Mbp) detected | |||
TP53 status | |||
positive | 8 (62) | 4 (17) | |
negative | 5 (38) | 20 (83) | p = 0.005 (chi-2) |